Eman El-Wakil | Microbiology | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Eman El-Wakil | Microbiology | Best Researcher Award

Assoc. Prof. Dr. Eman El-Wakil , Theodor Bilharz Research Institute , Egypt

Dr. Eman Sayed Shabrawy El-Wakil is an Associate Professor and Consultant of Medical Parasitology at the Theodor Bilharz Research Institute (TBRI), Egypt. Born on November 21, 1985, she has been deeply engaged in research and diagnostics of parasitic diseases, particularly focusing on molecular characterization, novel therapeutics, and gut microbiota-parasite interaction. With multiple peer-reviewed publications, she contributes to advancing parasitological science both in Egypt and internationally. She earned her M.D. in Medical Parasitology from Cairo University, and her scholarly reputation is supported by memberships and indexed profiles on ResearchGate, Google Scholar, Scopus, and ORCID. Dr. El-Wakil’s work has received notable accolades, including the prestigious TBRI award for the best doctoral research. She is also a reviewer for multiple journals and collaborates on multidisciplinary research tackling emerging parasitic threats. Her vision integrates research, education, and public health improvement through evidence-based parasitology.

Publication Profile:

Scopus

✅ Strengths for the Award:

Dr. Eman Sayed Shabrawy El-Wakil stands out as a prominent figure in Medical Parasitology, with an impressive track record in research, publication, and applied therapeutics. Her strengths include:

  • Robust Research Output: With over 12 peer-reviewed publications in high-impact international journals between 2023–2025, her work addresses critical parasitic diseases like Cryptosporidiosis, Trichinellosis, Toxoplasmosis, and Entamoeba infections.

  • Innovative Methodologies: She has pioneered green synthesis, nanoparticle-based therapies, in silico modeling, and immunomodulatory strategies, showcasing her multidimensional expertise.

  • Academic Leadership: As an Associate Professor and Consultant at TBRI, she contributes to teaching, mentoring, and national public health research priorities.

  • International Recognition: Indexed in Scopus, Google Scholar, ORCID, and Web of Science, and recipient of the TBRI Award for the best doctoral research in 2021.

  • Interdisciplinary Collaboration: Engaged in research across nanomedicine, pharmacology, microbiota-parasite interactions, and immunotherapy.

🔍 Areas for Improvement:

While Dr. El-Wakil’s profile is distinguished, some areas can be enhanced to strengthen her global impact:

  • Increased Global Engagement: Participation in more international collaborative projects, conferences, and consortia would amplify the reach of her research.

  • Grant Acquisition: Pursuing competitive research funding (e.g., WHO, NIH, EU Horizon) would facilitate larger-scale studies and clinical applications.

  • Patents and Translational Outputs: Exploring patenting opportunities for her innovative therapeutic agents could position her as a translational research leader.

🎓 Education:

Dr. El-Wakil earned her Master’s (M.Sc.) in Medical Parasitology with Excellent distinction in May 2015, and her Doctorate (M.D.) in Medical Parasitology in May 2018 from the Faculty of Medicine, Cairo University. Her educational path is marked by excellence in theoretical and applied parasitology, encompassing key disciplines like Molecular Parasitology, Immunology, and Medical Parasitology. Her M.D. thesis, titled “Isolation and Molecular Characterization of Free-Living Amoebae from Water Sources in Egypt”, reflected her early interest in environmental parasitology and public health. The academic structure of her doctoral program integrated critical courses in host-parasite interactions and advanced diagnostic techniques, equipping her with both field and laboratory expertise. Her education established a strong foundation for a career defined by innovation, critical thinking, and translational research in parasitic diseases.

💼 Experience:

Currently serving as an Associate Professor and Consultant at TBRI’s Parasitology Department, Dr. El-Wakil brings over a decade of expertise in diagnostics, molecular biology, and experimental parasitology. She operates within the Immunology and Drug Evaluation Division, where she contributes to therapeutic investigations and drug repurposing studies targeting helminths and protozoa. Her consultancy role extends to research mentorship, scientific reviews, and diagnostic innovations for parasitic infections in Egypt. She also works closely with governmental and academic institutions under the Ministry of Higher Education and Scientific Research. Her leadership roles in various inter-institutional projects have propelled the institute’s visibility in parasitology. She also manages collaborations involving nanotechnology, bioinformatics, and herbal medicine as potential parasitic treatments. Dr. El-Wakil exemplifies a blend of academic rigor and applied science, aligning her role with national health priorities and global research trends.

🏅 Honors and Awards:

Dr. El-Wakil was honored with the Theodor Bilharz Research Institute Award in 2021 for the best research derived from a doctoral dissertation—an acknowledgment of her innovation in parasitological research. This award recognized her pioneering work on free-living amoebae and her methodological precision. In addition to institutional awards, her research has been showcased in multiple open-access international journals, and she frequently receives commendations for excellence in experimental design and publication impact. Her work on novel anti-parasitic agents and immunotherapeutic approaches has attracted attention in scientific forums. She has also contributed to multi-author reviews on global health topics such as SARS-CoV-2 vaccines, highlighting her versatility as a researcher. Her awards reflect both her depth of knowledge and the real-world applicability of her research in enhancing public health outcomes.

🔬 Research Focus:

Dr. El-Wakil’s research concentrates on the epidemiology, molecular diagnostics, and therapeutic strategies for parasitic infections. Her work integrates natural product pharmacology, nanotechnology-based delivery systems, and immune modulation therapies. Her investigations cover a broad spectrum of parasites, from protozoa like Cryptosporidium and Entamoeba, to helminths such as Trichinella spiralis. Recent research includes green synthesis of nanoparticles, bioinformatics-based molecular docking, and gut microbiota-parasite interactions. A recurring theme in her research is the repurposing of existing drugs for parasitic treatment, evaluated both in vitro and in vivo. She also explores the interplay between host immunity and parasitic infection using molecular signaling pathways such as P2X7 receptors. Her focus on translational parasitology bridges basic research and therapeutic innovation, providing insights into both endemic and emerging infections in Egypt and beyond.

📚 Publications Top Notes:

  1. 🍊 Green Synthesis of Chitosan/Silver Nanoparticles Using Citrus paradisi Extract and Its Potential Anti-Cryptosporidiosis Effect

  2. 🧬 Microbiota-Parasite Interaction: Implication of Secretory Immunoglobulin A and P2X7 Receptor Signaling

  3. 🌿 Repurposing Drugs to Treat Trichinellosis: In Vitro Analysis of Nifedipine and Chrysanthemum coronarium Extract

  4. 🧪 Prevalence and Molecular Identification of Entamoeba Species Complex in Egyptians

  5. 📊 Mapping Gut Parasitism Patterns in a Cohort of Egyptians

  6. 🍃 Annona Muricata Leaf as an Anti-Cryptosporidial Agent: In Silico and In Vivo Study

  7. 🌼 Prophylactic and Therapeutic Effects of Kaempferol on Experimental Trichinella Spiralis

  8. 💊 Surfactant Vesicles for Enhanced Antitoxoplasmic Effect of Norfloxacin

  9. 🧾 SARS-CoV-2 Vaccines from A to Z: A Review of the Current Challenges

  10. 💉 Albendazole and Berberine Nanoparticles in Experimental Trichinellosis

  11. 🌿 Therapeutic Efficacy of Silymarin on Intestinal and Muscular Phases of Trichinellosis

  12. 🧫 Trichinella spiralis Antigens for Inflammatory Bowel Disease: Immunotherapeutic and Prophylactic Potential

🧾 Conclusion:

Dr. Eman S. El-Wakil demonstrates excellence in research productivity, scientific innovation, and professional engagement. Her contributions to parasitology—especially in the field of therapeutic innovation using natural compounds and nanoparticles—mark her as an emerging leader in her field. Given her academic rigor, publication record, and commitment to tackling parasitic diseases of global health concern, she is an outstanding candidate for the Best Researcher Award.

Dana Hassouneh | Microbial Cell Biology | Best Researcher Award

Posted on by sciencefather

Dr. Dana Hassouneh | Microbial Cell Biology | Best Researcher Award

Dr. Dana Hassouneh , King Hussein Cancer Center , Jordan

Dana Hassouneh is a dedicated Clinical Pharmacist from Amman, Jordan, with extensive experience working in hospitals, clinics, and community pharmacies. Passionate about patient-centered care, Dana is committed to enhancing medication therapies while continuously expanding her medical knowledge. Dana’s professional expertise includes inpatient pharmacy, chemotherapy, patient counseling, and drug interactions. As a co-investigator in research, she is also deeply involved in improving healthcare outcomes, particularly in oncology. Dana’s strong communication, organizational, and counseling skills have made her a valuable asset in the healthcare field. She is an advocate for educating patients and healthcare professionals to ensure proper medication use and adherence to prescribed therapies.

Publication Profile: 

Orcid

Strengths for the Award 💪

Dana Hassouneh exhibits a strong commitment to patient-centered care and advanced research in the field of clinical pharmacy, particularly in oncology and infectious diseases. Her contributions as a co-investigator in high-impact research, such as the study on microbiological profiles and resistance patterns in pediatric cancer patients, reflect her deep analytical skills and her dedication to improving patient outcomes. Dana’s ability to bridge the gap between clinical practice and research is a standout feature, making her an invaluable asset to the medical community. Her research at the King Hussein Cancer Center, which includes investigating community-acquired pneumonia in cancer patients, demonstrates her ability to approach complex medical problems with a scientific mindset and her willingness to engage in meaningful work to advance healthcare.

Areas for Improvements 🌱

While Dana’s expertise is remarkable, there is always room to expand her research focus and broaden her collaborative network. Increasing her involvement in multi-center, international research collaborations could offer her exposure to a wider variety of data and perspectives, further strengthening her research abilities. Moreover, refining advanced statistical analysis skills and gaining additional training in emerging research methodologies could contribute to more robust and innovative findings. Dana could also consider focusing on improving interdisciplinary collaborations, especially between clinical pharmacy, microbiology, and oncology to enhance her ability to address multifaceted medical challenges.

Education 🎓

Dana graduated from the University of Jordan with a Clinical Pharmacist degree in 2021, achieving an impressive 3.69/4 GPA. Prior to this, she completed her IGCSE studies at Global International School, where she earned a remarkable score of 97.6/100. Throughout her academic journey, Dana has demonstrated exceptional skills in pharmacology and therapeutic practices, laying the foundation for her successful career as a clinical pharmacist. Her education has enabled her to integrate evidence-based medicine into her practice while developing the skills necessary for medication therapy management and patient education. Dana’s academic excellence continues to influence her ongoing professional growth, furthering her ability to contribute to the medical field and improve patient outcomes.

Experience 💼

Dana’s career began at Luqman Al-Hakeem Pharmacy, where she gained valuable patient interaction skills while dispensing medications and offering counseling. Later, as a clinical pharmacist at the King Hussein Cancer Center, Dana worked both in inpatient and chemotherapy pharmacies, ensuring safe medication therapy for cancer patients. Her role involved educating healthcare professionals about drug interactions and alternative therapies. Dana’s research experience as a co-investigator has also been significant, analyzing patient outcomes for those with community-acquired pneumonia. She has also trained at various healthcare settings such as Jordan University Hospital and Jordanian Royal Medical Services, enhancing her knowledge of patient medication management and adherence. This diverse experience has honed Dana’s clinical expertise and strengthened her passion for improving patient care and outcomes.

Research Focus 🔬

Dana’s research primarily focuses on improving patient outcomes through medication therapy management and investigating disease-specific therapies. Her recent work as a co-investigator at King Hussein Cancer Center involves studying the characteristics and outcomes of patients with community-acquired pneumonia. Dana is deeply engaged in the process of manuscript writing and data analysis, with a focus on oncology and infectious diseases. She has also contributed to research regarding microbiological profiles and resistance patterns in pediatric cancer patients. Her research aims to provide evidence-based solutions that can enhance treatment protocols, reduce medication errors, and optimize healthcare delivery for cancer patients. Dana’s work contributes to bridging the gap between clinical practice and research, ensuring that patients receive the best possible care based on up-to-date scientific evidence.

Publications Top Notes 📚

Microbiological Profiles and Resistance Patterns in Pediatrics With Cancer: An 8‐Year Study at a Comprehensive Cancer Center in Jordan – Cancer Reports (2025-03)

Conclusion 🎯

Dana Hassouneh’s blend of clinical practice and research expertise makes her an excellent candidate for the Research for Best Researcher Award. Her strengths in patient education, counseling, and collaboration with multidisciplinary teams position her as an emerging leader in the field. As she continues to develop her research focus and expands her skill set, Dana is poised to contribute significantly to advancements in clinical pharmacy and oncology research. Her passion, diligence, and commitment to improving patient care are undeniable, making her a valuable asset to the healthcare field.

Chong-Miao Zhang | Microbial Cell Biology | Best Researcher Award

Posted on by sciencefather

Prof. Chong-Miao Zhang | Microbial Cell Biology | Best Researcher Award

Prof. Chong-Miao Zhang , Xi’an University of Architecture and Technology , China

Prof. Chong-Miao Zhang, Ph.D., is a distinguished Professor and Ph.D. Supervisor at Xi’an University of Architecture and Technology, China. He is a recognized member of the International Water Association (IWA) and holds influential positions in the Water Treatment and Reuse Professional Committee of the Chinese Society for Environmental Sciences and the Shaanxi Provincial Society of Toxicology. Prof. Zhang has dedicated his career to advancing research in environmental science and engineering. His efforts have led to numerous achievements, including over 100 published academic papers, several patented inventions, and the completion of multiple projects funded by the National Natural Science Foundation of China. He is a celebrated educator and researcher in the field of environmental health and wastewater treatment.

Publication Profile:

Scopus

Strengths for the Award:

Prof. Chong-Miao Zhang is highly deserving of the Best Researcher Award due to his outstanding contributions to environmental science and engineering. His work on environmental risk assessments, biological pollutants, and antibiotic resistance provides crucial insights into sustainable practices for wastewater reclamation and environmental health. He has successfully completed major research projects funded by the National Natural Science Foundation of China and the Key Research and Development Project of Shaanxi Province. Furthermore, Prof. Zhang has published over 100 papers in prestigious journals and holds 7 patents. His influence extends beyond research, with his active membership in key environmental societies and professional committees.

Areas for Improvement:

Although Prof. Zhang’s research output is impressive, further emphasis on the interdisciplinary application of his findings to real-world policy or industrial solutions could amplify his impact. Additionally, collaborations with international researchers could enhance the global applicability of his work. Increasing citation rates of his more recent papers would further solidify his standing in the scientific community.

Education:

Prof. Zhang holds a Ph.D. in Environmental Engineering from a prestigious institution, where he honed his expertise in environmental sciences, focusing on risk assessment, water treatment, and pollutants’ impact on human health. His educational background has equipped him with deep knowledge in both biological and chemical aspects of environmental engineering, enabling his success in various high-profile research projects. Prof. Zhang’s academic journey laid the foundation for his current work in advancing sustainable solutions for water reclamation and the detection of emerging pollutants. His training and educational path have made him an expert in handling complex environmental challenges, shaping his career toward becoming a leader in environmental research and policy development.

Experience:

Prof. Chong-Miao Zhang has extensive experience in both academia and research, serving as a Professor and Ph.D. Supervisor at Xi’an University of Architecture and Technology. He has led various national and provincial research projects, including those funded by the National Natural Science Foundation of China. His research has primarily focused on environmental engineering, biological pollutants, antibiotic resistance, and water treatment technologies. Prof. Zhang’s leadership is evident in his ability to guide multidisciplinary teams, publish over 100 academic papers, and secure patents. Furthermore, his involvement in professional committees, such as the Water Treatment and Reuse Professional Committee and Shaanxi Provincial Microbiology Society, has enhanced his reputation as a key figure in environmental sciences and public health.

Research Focus:

Prof. Zhang’s research primarily focuses on the risk assessment of biological pollutants, antibiotic resistance genes, and the detection and ecotoxicology of emerging pollutants like antibiotics and microplastics. His work investigates the impacts of pollutants in wastewater and their environmental consequences. He also conducts extensive research on the ecological and toxicological effects of contaminants, including antihistamine drugs such as loratadine, and the conjugative transfer of antibiotic resistance genes. Prof. Zhang’s research aims to develop advanced methods for environmental risk mitigation and improve water treatment practices to enhance sustainability and public health protection. His interdisciplinary approach makes him a leading expert in environmental risk assessment, wastewater treatment, and pollutant ecology.

Publications Top Notes:

  • “Antihistamine drug loratadine at environmentally relevant concentrations promotes conjugative transfer of antibiotic resistance genes: Coeffect of oxidative stress and ion transport” (2025) 📄
  • “Eliminating bacterial endotoxins and associated inhalation hazards in reclaimed water via ultraviolet/ferrate combination disinfection” (2025) 📄
  • “Characteristics of heterotrophic endophytic bacteria in four kinds of edible raw vegetables: species distribution, antibiotic resistance, and related genes” (2024) 📄
  • “Inhalation of ferrate-disinfected Escherichia coli caused lung injury via endotoxin-induced oxidative stress and inflammation response” (2024) 📄
  • “Effects of gradual increase of ciprofloxacin and cefotaxime on nitrogen and phosphorus removal and microbial community in moving bed biofilm reactor” (2024) 📄
  • “Variation Characteristics of Endotoxin Concentration and Its Occurrence During Chlorine Disinfection of Bacteria Contaminated Water” (2024) 📄
  • “Metagenomic insights into effects of carbon/nitrogen ratio on microbial community and antibiotic resistance in moving bed biofilm reactor” (2024) 📄

Conclusion:

Prof. Zhang’s exceptional contributions to environmental engineering, innovative research on pollutant detection, and expertise in microbial communities make him an exemplary candidate for the Best Researcher Award. His ability to integrate cutting-edge science with practical solutions demonstrates his potential for future breakthroughs in environmental science and engineering. Prof. Zhang’s continued influence in this field positions him as a key thought leader for global environmental sustainability challenges.